- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2095-0225
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Chimeric antigen receptor T cell therapies for acute myeloid leukemia ; volume:14 ; number:6 ; day:1 ; month:12 ; year:2020 ; pages:701-710 ; date:12.2020
Frontiers of medicine ; 14, Heft 6 (1.12.2020), 701-710, 12.2020
- Creator
-
Gu, Bin
Chu, Jianhong
Wu, Depei
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s11684-020-0763-z
- URN
-
urn:nbn:de:101:1-2021030421114821782698
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:22 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Gu, Bin
- Chu, Jianhong
- Wu, Depei
- SpringerLink (Online service)
Other Objects (12)
Chimeric antigen receptor T cells for acute myeloid leukemia
Chimeric antigen receptors for adoptive T cell therapy in acute myeloid leukemia
Chimeric antigen receptor–based therapies beyond cancer
Emerging therapies for acute myeloid leukemia
Chimeric antigen receptor (CAR)-modified T cells targeting FLT3 in acute myeloid leukemia (AML)
Current limitations and perspectives of chimeric antigen receptor-T-cells in acute myeloid leukemia
Chimeric antigen receptor T cell therapies for multiple myeloma
Targeting FLT3 in acute myeloid leukemia using ligand-based chimeric antigen receptor-engineered T cells
Resistance to targeted therapies in acute myeloid leukemia
Recent advances in targeted therapies in acute myeloid leukemia
Generation and evaluation of chimeric antigen receptor-modified natural killer cells for the treatment of acute myeloid leukemia
Site-specific transgene integration in chimeric antigen receptor (CAR) T cell therapies
Chimeric antigen receptor T cells for acute myeloid leukemia
Chimeric antigen receptors for adoptive T cell therapy in acute myeloid leukemia
Chimeric antigen receptor–based therapies beyond cancer
Emerging therapies for acute myeloid leukemia
Chimeric antigen receptor (CAR)-modified T cells targeting FLT3 in acute myeloid leukemia (AML)
Current limitations and perspectives of chimeric antigen receptor-T-cells in acute myeloid leukemia
Chimeric antigen receptor T cell therapies for multiple myeloma
Targeting FLT3 in acute myeloid leukemia using ligand-based chimeric antigen receptor-engineered T cells
Resistance to targeted therapies in acute myeloid leukemia
Recent advances in targeted therapies in acute myeloid leukemia
Generation and evaluation of chimeric antigen receptor-modified natural killer cells for the treatment of acute myeloid leukemia
Site-specific transgene integration in chimeric antigen receptor (CAR) T cell therapies
Chimeric antigen receptor T cells for acute myeloid leukemia
Chimeric antigen receptors for adoptive T cell therapy in acute myeloid leukemia
Chimeric antigen receptor–based therapies beyond cancer
Emerging therapies for acute myeloid leukemia
Chimeric antigen receptor (CAR)-modified T cells targeting FLT3 in acute myeloid leukemia (AML)
Current limitations and perspectives of chimeric antigen receptor-T-cells in acute myeloid leukemia
Chimeric antigen receptor T cell therapies for multiple myeloma
Targeting FLT3 in acute myeloid leukemia using ligand-based chimeric antigen receptor-engineered T cells
Resistance to targeted therapies in acute myeloid leukemia
Recent advances in targeted therapies in acute myeloid leukemia
Generation and evaluation of chimeric antigen receptor-modified natural killer cells for the treatment of acute myeloid leukemia